Enzymatica Reports Q3 Sales of SEK 14.6M as Operating Loss Narrows
Q3 net sales were SEK 14.6 million versus SEK 15.0 million. The operating loss narrowed; EPS was SEK -0.02 and operating cash flow was SEK -5.8 million.
Enzymatica AB reported Q3 net sales of SEK 14.6M vs SEK 15.0M and an operating result of SEK -3.9M vs SEK -8.2M. EPS was SEK -0.02. Cash flow from operations was SEK -5.8M.Material DetailsContext by AI AnalystThis is a mid-cycle update showing ongoing revenue softness but improved losses and cash b…